INS and type 2 diabetes mellitus: In this report, we describe the selectivity and potency of canagliflozin and characterize its effects on UGE, RTG, glycemic control, glucose-stimulated insulin secretion, energy expenditure, and body weight in preclinical models of T2DM and insulin resistance.